Cargando…
Potential Repurposed Therapeutics and New Vaccines against COVID-19 and Their Clinical Status
SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was first reported in Wuhan, China, in December 2019. Since then, the virus has stretched its grip to almost all the countries in the world, affecting millions of people and causing enormous casualties. The World Health Organizat...
Autores principales: | Banday, Abid H., Shameem, Shameem A., Ajaz, Sheikh J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Laboratory Automation and Screening. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960149/ https://www.ncbi.nlm.nih.gov/pubmed/32692266 http://dx.doi.org/10.1177/2472555220945281 |
Ejemplares similares
-
Antimicrobial studies of unsymmetrical bis-1,2,3-triazoles
por: Banday, Abid H, et al.
Publicado: (2012) -
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
por: Saha, Rudra P., et al.
Publicado: (2020) -
Binary Simulated Normal Distribution Optimizer for feature selection: Theory and application in COVID-19 datasets
por: Ahmed, Shameem, et al.
Publicado: (2022) -
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development
por: Yim, Joowon, et al.
Publicado: (2021) -
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
por: Raghav, Pawan Kumar, et al.
Publicado: (2023)